We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$373M
(+5.3%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
62.33%
Holding
1,161
New
145
Increased
742
Reduced
165
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$55.7M |
| 2 |
iShares Gold Trust
IAU
|
+$31.5M |
| 3 |
Hyatt Hotels
H
|
+$22.1M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$18M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$20.2M |
| 2 |
Celldex Therapeutics
CLDX
|
+$15.3M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.52M |
| 4 |
Palantir
PLTR
|
+$4.79M |
| 5 |
RTX Corp
RTX
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.28% |
| 2 | Consumer Discretionary | 6.79% |
| 3 | Healthcare | 3.4% |
| 4 | Financials | 3.36% |
| 5 | Communication Services | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Wells Fargo
WFC
$264B
| $2.37M | 0.03% |
51,170
+12,221
| +31% | +$566K |
|
202
West Pharmaceutical
WST
$24.9B
| $2.34M | 0.03% |
5,521
+2,040
| +59% | +$860K |
|
203
Virgin Galactic
SPCE
$398M
| $2.33M | 0.03% |
4,597
-403
| -8% | -$239K |
|
204
S&P Global
SPGI
$120B
| $2.33M | 0.03% |
5,471
+1,341
| +32% | +$581K |
|
205
Eaton
ETN
$174B
| $2.32M | 0.03% |
15,537
+815
| +6% | +$130K |
|
206
Twilio
TWLO
$36.6B
| $2.29M | 0.03% |
7,183
+953
| +15% | +$347K |
|
207
Schwab International Small-Cap Equity ETF
SCHC
$5.66B
| $2.28M | 0.03% |
+54,974
| New | +$2.34M |
|
208
CRISPR Therapeutics
CRSP
$5.17B
| $2.21M | 0.03% |
19,786
+670
| +4% | +$84.1K |
|
209
Stryker
SYK
$130B
| $2.21M | 0.03% |
8,363
+330
| +4% | +$88.2K |
|
|
EDD
210
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$385M
| $2.2M | 0.03% |
370,184
| – | – |
|
211
Snap
SNAP
$9.01B
| $2.2M | 0.03% |
29,793
+4,223
| +17% | +$305K |
|
|
MMP
212
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $2.18M | 0.03% |
47,889
+22,130
| +86% | +$1.05M |
|
213
Microchip Technology
MCHP
$46B
| $2.17M | 0.03% |
28,316
+28
| +0.1% | +$2.1K |
|
214
Williams Companies
WMB
$86.1B
| $2.17M | 0.03% |
83,730
+37,500
| +81% | +$944K |
|
215
Zillow
Z
$7.56B
| $2.17M | 0.03% |
24,643
+1,058
| +4% | +$107K |
|
216
Baidu
BIDU
$37.2B
| $2.16M | 0.03% |
14,066
-268
| -2% | -$44K |
|
217
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.38B
| $2.15M | 0.03% |
42,535
+36,535
| +609% | +$1.85M |
|
218
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
| $2.14M | 0.03% |
10,670
-3,187
| -23% | -$659K |
|
219
Idexx Laboratories
IDXX
$46.2B
| $2.14M | 0.03% |
3,447
+170
| +5% | +$114K |
|
220
State Street SPDR S&P Dividend ETF
SDY
$23.9B
| $2.14M | 0.03% |
18,233
+114
| +0.6% | +$14K |
|
221
Zoom
ZM
$30.6B
| $2.13M | 0.03% |
8,156
+3,058
| +60% | +$1.03M |
|
222
Novartis
NVS
$297B
| $2.12M | 0.03% |
25,962
+5,478
| +27% | +$493K |
|
|
NVO
223
Novo Nordisk
NVO
$209B
| $2.09M | 0.03% |
43,588
+5,888
| +16% | +$285K |
|
224
Unity
U
$18.9B
| $2.09M | 0.03% |
16,543
+1,999
| +14% | +$237K |
|
225
Micron Technology
MU
$991B
| $2.08M | 0.03% |
29,188
+1,517
| +5% | +$114K |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cresset Asset Management held 1,161 positions worth $7.43B, up 5.3% from $7.06B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Cresset Asset Management deployed $381M of net new capital in Q3 2021, opening 145 new positions and adding to 742 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $20.2M trimmed.
- Cresset Asset Management's largest Q3 2021 buy was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
- Cresset Asset Management added most to ARK Innovation ETF in Q3 2021, an estimated $55.7M increase.
- Cresset Asset Management's biggest Q3 2021 reduction was Apple, cutting an estimated $20.2M.
- Cresset Asset Management fully exited Celldex Therapeutics in Q3 2021, selling an estimated $15.3M.
- Cresset Asset Management's ten largest holdings make up 62% of its $7.43B portfolio in Q3 2021.
- Cresset Asset Management opened 145 new positions and closed 58 in Q3 2021.
- Cresset Asset Management's portfolio value rose 5.3% quarter-over-quarter to $7.43B.
Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.